References
Shiffman ML, Suter F, Bacon BR, et al. Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. N Engl J Med. 2007;357:124-134.
Wong T, Lee SS. Hepatitis C: a review for primary care physicians. CMAJ. 2006;174:649-659.
Rocca LG, et al. Management of patients with hepatitis C in a community setting: diagnosis, discussions and decisions to treat. Ann Fam Med. 2004;2:116-124.